Global Blood Purification Market Size By Type (General Type, Type II), By Application (Medical, Application II), By Region, And Segment Forecasts, 2023 to 2032

The Global Blood Purification Market was valued at USD 18.2 billion in 2023 and is projected to surpass USD 31.5 billion by 2031, growing at a CAGR of 6.8% during the forecast period 2023-2031. The increasing prevalence of chronic kidney disease (CKD), end-stage renal disease (ESRD), and autoimmune diseases is driving the demand for blood purification therapies. Rising technological advancements in dialysis and hemofiltration systems, along with growing healthcare expenditure, are key factors fueling market expansion.

With the increasing burden of sepsis, metabolic disorders, and multiple organ failure (MOF), blood purification therapies such as hemodialysis, hemofiltration, plasmapheresis, and immunoadsorption have gained significant traction. Furthermore, growing awareness about extracorporeal blood purification techniques and favorable reimbursement policies are expected to further accelerate market growth.

Drivers:

1. Increasing Prevalence of Kidney-Related Disorders

The rising incidence of chronic kidney diseases (CKD) and end-stage renal disease (ESRD) globally has propelled the demand for blood purification therapies. According to the International Society of Nephrology, nearly 10% of the global population suffers from CKD, with millions requiring dialysis or transplantation.

2. Growing Adoption of Blood Purification in Sepsis Treatment

Sepsis-induced multiple organ failure (MOF) is a major contributor to mortality in ICU patients. Advanced hemofiltration and adsorption therapies are increasingly being integrated into sepsis treatment, reducing inflammatory mediators and improving patient survival rates.

3. Advancements in Blood Purification Technologies

Innovations in membrane-based purification, portable dialysis machines, and AI-driven dialysis monitoring systems have enhanced treatment efficiency, reducing hospitalization rates and treatment costs.

Restraints:

1. High Cost of Blood Purification Therapies

Advanced blood purification therapies, including immunoadsorption and plasmapheresis, require expensive equipment and operational costs, limiting their accessibility in low-income regions.

2. Risk of Infections and Complications

Blood purification techniques involve direct contact with the bloodstream, posing risks such as infection, clotting disorders, and hypotension, which can lead to severe complications.

Opportunity:

1. Rising Demand for Home-Based Dialysis Solutions

The COVID-19 pandemic highlighted the need for portable and home-based dialysis machines, driving innovation in peritoneal dialysis and wearable blood purification systems.

2. Market Expansion in Emerging Economies

Countries like India, China, and Brazil are witnessing significant improvements in healthcare infrastructure, increasing the adoption of affordable blood purification therapies.

3. Growing Research in Bioartificial Kidneys

The development of bioartificial kidneys and regenerative medicine for renal failure treatment presents lucrative opportunities for market players in the long term.

Market by System Type Insights:

1. Hemodialysis Equipment – Largest Segment

The hemodialysis segment accounted for the largest market share in 2023, driven by the increasing CKD patient pool and technological advancements in high-flux membranes.

2. Hemoperfusion and Plasmapheresis – Fastest Growing Segment

With the rising incidence of sepsis, autoimmune disorders, and metabolic diseases, the hemoperfusion and plasmapheresis segment is projected to witness the highest CAGR during the forecast period.

Market by End-Use Insights:

1. Hospitals & Dialysis Centers – Dominant Market Share

Hospitals and dialysis centers accounted for over 65% of the global blood purification market in 2023, owing to the availability of advanced hemodialysis machines and critical care units.

2. Homecare Settings – Emerging Growth Area

The home dialysis segment is expected to grow rapidly, fueled by patient preference for home-based treatment, government initiatives for cost reduction, and advancements in compact dialysis devices.

Market by Regional Insights:

1. North America – Leading Market

North America dominated the global blood purification market in 2023, driven by the high prevalence of CKD and ESRD, strong healthcare infrastructure, and increasing adoption of portable dialysis solutions.

2. Asia-Pacific – Fastest Growing Region

The Asia-Pacific region is expected to witness the highest CAGR due to rising healthcare expenditure, increasing awareness about kidney disorders, and improving reimbursement policies.

Competitive Scenario:

Key players in the Global Blood Purification Market include:

Baxter International Inc.

Fresenius Medical Care AG & Co. KGaA

Nikkiso Co., Ltd.

Asahi Kasei Medical Co., Ltd.

Toray Medical Co., Ltd.

B. Braun Melsungen AG

Kaneka Corporation

Jafron Biomedical Co., Ltd.

Cytosorbents Corporation

Medtronic plc

Recent Key Developments:

March 2023: Baxter International launched a next-generation portable dialysis machine with AI-based monitoring to enhance home dialysis treatments.

August 2023: Fresenius Medical Care collaborated with a leading biotech company to develop an advanced bioartificial kidney model.

December 2023: Cytosorbents Corporation received FDA approval for its latest cytokine-adsorbing hemoperfusion device for sepsis treatment.

Scope of Work – Global Blood Purification Market